

Eagle's Eye View: Your Weekly CV Update From ACC.org
American College of Cardiology
The weekly cardiovascular update from Kim Eagle, MD, MACC for ACC.org covering the hottest cardiovascular topics, from new clinical guidelines to practice-changing research and innovative quality initiatives and tools.
Episodes
Mentioned books

Jun 5, 2024 • 11min
Anticoagulation in Post-Operative AFib, Non-ST-Elevation Acute Coronary Syndromes, Arrhythmia-Induced Cardiomyopathy
This podcast explores anticoagulation in post-operative AFib, invasive vs. conservative management of non-STEMI, and reviews arrhythmia-induced cardiomyopathy. Dr. Eagle shares insights on these topics in a concise and informative manner.

May 29, 2024 • 8min
Aortic Valve Calcification and Aortic Stenosis, Microvascular Resistance Reserve After PCI, Microvascular Injury Patterns
In this week’s View, Dr. Eagle looks at the diagnostic value of aortic valve calcification levels in the assessment of low-gradient aortic stenosis. He then examines the prognostic value of microvascular resistance reserve after percutaneous coronary intervention in patients with myocardial infarction. Finally, Dr. Eagle shares some thoughts on clinical outcomes associated with various microvascular injury patterns identified by cardiac MRI after STEMI. Subscribe to Eagle’s Eye View

May 22, 2024 • 10min
Transcatheter-Based Intervention and Tetralogy of Fallot, Small Left Ventricle and Atrial Fibrillation (Afib), Aspirin Free Treatment Post-PCI
In this week’s View, Dr. Eagle looks at transcatheter-based intervention for tetraology of Fallot. He then examines how a small left ventricle in patients with atrial fibrillation is associated with increased cardiovascular risk. Finally, Dr. Eagle shares some thoughts on an aspirin-free strategy for immediate treatment following complex percutaneous coronary intervention. Subscribe to Eagle’s Eye View

May 15, 2024 • 11min
Guideline for the Management of Lower Extremity Peripheral Artery Disease (PAD), Decongestion Strategies for Heart Failure, Lipoproteins and Triglycerides in Cardiovascular Prevention
In this week’s View, Dr. Eagle looks at the recently released guidelines for lower extremity peripheral arterial disease (PAD). He then examines a national community-based cohort study on contemporary decongestion strategies in patients hospitalized for heart failure. Finally, Dr. Eagle shares some thoughts on the implications of discordance among ApoB, non–high-density lipoprotein cholesterol and triglycerides for cardiovascular prevention. Subscribe to Eagle’s Eye View

May 8, 2024 • 11min
Eagle’s Eye View: The New AHA/ACC Hypertrophic Cardiomyopathy Guideline, Smoking Cessation, Embolic Stroke
In this week’s View, Dr. Eagle looks at the new AHA/ACC Hypertrophic Cardiomyopathy Guideline, then examines a randomized clinical trial that studied smoking cessation after initial treatment failure with varenicline or nicotine. Finally, Dr. Eagle shares some thoughts on a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging, and the European Heart Rhythm Association of the ESC on embolic strokes of an undetermined source. Subscribe to Eagle’s Eye View

May 1, 2024 • 9min
Eagle’s Eye View: Pulsed Field Ablation and Pulmonary Vein Isolation, Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives, TAVR or SAVR and Severe Aortic Stenosis
In this week’s View, Dr. Eagle looks at the durability of pulmonary vein isolation using pulsed-field ablation, then examines genetic penetrance of dilated cardiomyopathy in genotype-positive relatives. Finally, Dr. Eagle shares some thoughts on reinterventions after CoreValve/Evolut TAVR or SAVR for treatment of severe aortic stenosis. Subscribe to Eagle’s Eye View

Apr 24, 2024 • 10min
Eagle’s Eye View: Cardiac Sarcoidosis, Ischemic Stroke in Women with Atrial Fibrillation, TAVR and Native Aortic Regurgitation
In this week’s View, Dr. Eagle looks at a scientific statement from the American Heart Association on the diagnosis and management of cardiac sarcoidosis. He then examines the temporal trends and clinical implications of ischemic stroke in women with atrial fibrillation. Finally, Dr. Eagle shares some thoughts on transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR). Subscribe to Eagle’s Eye View

Apr 17, 2024 • 10min
Eagle’s Eye View: infective Endocarditis After Invasive Dental Procedures, Serious Bleeding in Patients with Atrial Fibrillation Using Diltiazem with Apixaban or Rivaroxaban, Low-Dose Colchicine for Secondary Prevention in Atherosclerosis
In this week’s View, Dr. Eagle looks at a systematic review and meta-analysis of antibiotic prophylaxis and infective endocarditis incidence following invasive dental procedures. He then examines the issue of serious bleeding in patients with atrial fibrillation using diltiazem with apixaban or rivaroxaban. Finally, Dr. Eagle shares some thoughts on low-dose colchicine for secondary prevention in atherosclerosis. Subscribe to Eagle’s Eye View

Apr 10, 2024 • 4min
Eagle’s Eye View: Introducing ACC24
A special edition introducing ACC24 with insights into practice-changing updates, new drugs, and device therapies. Top experts debate and discuss results of trials, share visual abstracts, and show how it fits into practice. Transformation of care begins at ACC.24.

Apr 8, 2024 • 10min
Eagle’s Eye View: Day 3 -- ACCess Points Daily Wrap Up | ACC 2024
Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane review the late-breaking clinical trials from Day 3, Monday, April 7 at the American College of Cardiology Scientific Sessions 2024 in Atlanta. Trials on Monday include TARGET BP I (0:39), DEDICATE-DZHK6 (3:07), and FULL REVASC (6:31). For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page. Follow the ACC on Social Media and use the hashtag #ACC24. Subscribe to Eagle’s Eye View